Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Medical Devices
Overview
Conditions
Intellectual Property
Research
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma
Name:
Email:

Yes, in addition to e-alerts, please sign me up to receive Nutra Pharma Blog postings via email.

Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Conditions

Nutra Pharma, through its medical devices subsidiary Designer Diagnostics, is taking on some of the world's most difficult diseases including Nontuberculous Mycobacteria (NTM) and Tuberculosis (TB)

Nontuberculous Mycobacteria (NTM)
Nontuberculous Mycobacteria (NTM), also known as atypical Tuberculosis (Atypical TB) or Mycobacterium other than Tuberculosis (MOTT), is a bacteria that is found in water, some domestic and wild animals, and soil. NTM is a primary cause of respiratory disease in humans and is a leading cause of death in HIV/AIDS patients.
Additional Information: Stop NTM Now
 
 
Tuberculosis (TB)

Tuberculosis (abbreviated as TB for Tubercle Bacillus) is a common and deadly infectious disease caused by the bacterium Mycobacterium tuberculosis, which most commonly affects the lungs (pulmonary TB) but can also affect the central nervous system, lymphatic system, circulatory system, genitourinary system, bones and joints.

Additional Information: Stop TB Now
 
Quick Nav
 
Recent News
August 14, 2008
Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)


August 6, 2008
Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)


August 1, 2008
August 2008 Shareholder Letter from Chairman and CEO Rik J. Deitsch


 
 
Announcements
Click Here for an Update on the Phase IIb Clinical Trial Data.
 
 
NPC
Privacy Policy